跳到主内容
行业洞察美国 FDAT1064

Determination That Prednisolone Tablet, 5 Milligrams, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness

·22 天前·来源:美国 FDA

🤖 AI 摘要

The Food and Drug Administration (FDA or Agency) has determined that prednisolone tablet, 5 milligrams (mg), was not withdrawn from sale for reasons of safety or effectiveness. This determination means that FDA will not begin procedures to withdraw approval of abbreviated new drug applications (ANDAs) that refer to this drug product, and it will allow FDA to continue to approve ANDAs that refer to the product as long as they meet relevant legal and regulatory requirements.

分析模型:rule-based-v3 · 07-09 06:59

评分详情

综合分 64/100

信源权威

95

影响范围

70

时效性

50

合规紧急

40

行业关注

35

Federal Register: FDA Notices (官方通知)
操作:

相关推荐